FIELD: chemistry.
SUBSTANCE: present invention refers to the new compounds of formula 1: whereat : X is N or CH; R1 is selected from the group consisting of OSO2CH3, SOR4, SO2R4, SO2NH2, SO2NHCH3, SO2N(CH3)2, COR4, CN, OCF3, CF3, F, Cl, Br, I, CH(OH)CF3, CH2SO2CF3, CH2SO2CH3, CH2CF3, CH2COCH3, CH2COCF3; R2 is selected from the group consisting of CN, CF3, OH, OR4, F, CI, Br, I, CH3; R3 is selected from the group consisting of C1-C4 alkyls, allyl, CH2CH2OCH3, CH2CH2CH2F, CH2CH2CHF2, CH2CH2F, CH2CHF2, CH2CF3, 3,3,3-trifluoropropyl, 4,4,4-trifluorobuthyl; CH2CH2OH, CH2CH2CH2OH, CH2CH(OH)CH3, CH2CH2COCH3, , ;
R4 is selected from the group consisting of C1-C3 alkyls, CF3, CHF2, CH2F; provided that when R1 is CN, OCF3, CF3, F or Cl X is not CH, R2 is not F, CI, Br, CH3, and R3 is not C1-C3 alkyl or allyl; provided that when R1 is CF3 or CN, X is not CH, R2 is not F, CI, Br, CH3, and R3 is not C1-C2 alkyl; provided that when X is N: R1 is not Cl, when R2 is CH3, and R3 is CH2CH2OH; R1 is not Cl, when R2 is Cl, and R3 is CH3; R1 is not F, when R2 is CN, and R3 is CH3; R1 is not Cl, when R2 is Cl, and R3 is CH2CH2CH2OH; R1 is not Cl, when R2 is Cl, and R3 is CH2CH2OH; and provided that when R1 is SO2R4, SO2NH2, SO2NHCH3 or SO2N(CH3)2 R2 is not OH. The present invention refers also to the pharmaceutically acceptable salts of the said compounds, to the intermediate compounds, to their pharmaceutical composition as well as to the method of central nervous system abnormalities treatment.
EFFECT: obtaining of the new bioactive compounds active as modulators of dopamine neurotransmission.
43 cl, 79 ex, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED 4-(PHENYL-N-ALKYL)PIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT | 2000 |
|
RU2262504C2 |
2-CYANO-4-AMINOPYRIMIDINE COMPOUNDS WITH INHIBITOR ACTION ON CATHEPSIN K, PHARMACEUTICAL COMPOUND AND METHODS OF OBTAINING THEM (ALTERNATIVES) | 2002 |
|
RU2326119C2 |
NOVEL DOPAMINE NEUROTRANSMISSION MODULATORS | 2000 |
|
RU2386623C2 |
3-SUBSTITUTED 4-(PHENYL-N-ALKYL)-PIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHODS FOR TREATMENT | 2000 |
|
RU2265013C2 |
TETRAHYDROFURO(3,2-b)PYRROL-3-ONES AS CATHEPSIN K INHIBITORS | 2007 |
|
RU2456290C2 |
COMT INHIBITORS | 2013 |
|
RU2642779C2 |
SUBSTITUTED OXYDOL DERIVATIVES AND USE THEREOF AS VASOPRESSIN RECEPTOR LIGANDS | 2007 |
|
RU2461556C2 |
FLUORINE-18 AND CARBON-11 LABELED RADIOLIGANDS FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING FOR LRRK2 | 2012 |
|
RU2650641C2 |
CATHEPSIN-CYSTEINE PROTEASE INHIBITORS | 2003 |
|
RU2312861C2 |
OXAZINMONOACYLGLYCERIN LIPASE (MAGL) INHIBITORS | 2019 |
|
RU2794334C2 |
Authors
Dates
2009-09-10—Published
2005-06-08—Filed